Valvular Heart Disease: a Regurgitation of the Latest Antithrombotic Recommendations

June 14, 2022

 

This conference is being held virtually.

Target Audience

This course is intended for pharmacists

Learning Objectives

At the completion of this activity, the participant will be able to:

  1. Review the current guideline recommendations for antithrombotic therapy in patients with valvular heart disease
  2. Compare and contrast recent trials on antithrombotic therapy and pharmacological options
  3. Develop a treatment regimen using the appropriate antithrombic regimen for a patient with valvular heart disease
Course summary
Available credit: 
  • 1.00 Continuing Pharmacy Education (CPE)
    Aurora Health Care Department of Pharmacy Services is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education.
Course opens: 
06/13/2022
Course expires: 
07/21/2022
Event starts: 
06/14/2022 - 12:00pm CDT
Event ends: 
06/14/2022 - 1:00pm CDT
Cost:
$0.00
Rating: 
0

Faculty

Moataz Ali, PharmD, MBA - PGY1 Pharmacy Resident – Aurora Health Care Metro, Inc.

Disclosure

The planner(s) and speaker(s) have indicated that there are no relevant financial relationships with any ineligible companies to disclose.

 

 

 


1 contact hour of continuing pharmacy education (0.1 CEU) is available for pharmacist participants.  

Available Credit

  • 1.00 Continuing Pharmacy Education (CPE)
    Aurora Health Care Department of Pharmacy Services is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education.

Price

Cost:
$0.00
Please login or register to take this course.


Click “Take Course” to register for this program.  

This conference is being held virtually.  A  link to the meeting will be provided prior to the event.

Contact the AAH Pharmacy Continuing Education team at AAH-PharmacyCPEsubmission@aah.org if you have any questions or need assistance.